吡唑锌配合物的合成、晶体结构及抗肝癌细胞活性

通过溶剂挥发法合成了锌配合物[Zn(Hppo)2(ppo)Cl](1),Hppo=5-苯基-3-羟基吡唑,利用元素分析、FTIR以及X射线衍射法对配合物1进行表征。晶体结构显示配合物属于单斜晶系,P21空间群。检测了配合物1对肝癌细胞HepG2、Hep3B和Huh7的细胞形态与细胞毒性的影响,结果表明配合物1对肿瘤细胞具有明显的抑制作用。     

头孢氨苄水解物的镍/锌单核配合物的合成、晶体结构及抗肿瘤活性

以头孢氨苄(cephalexin)为原料合成锌和镍配合物,得到了2种新的单核配合物:[Ni(cepha)2]·6H2O (1)和[Zn(cepha)2]·6H2O(2)(cepha=cephalosporoate),通过元素分析、红外光谱、热重分析和X射线粉末衍射分析等方法表征1和2的结构,并通过X射线单晶衍射分析确定配合物的结构。配合物1和2均为正交晶系,空间群为P22121。头孢氨苄(cephalexin)在配位过程中发生水解产生头孢菌素中间体(cepha)并参与配位。金属离子与cepha形成六配位扭曲八面体几何构型,且通过分子间氢键将配合物进一步组装成三维网格结构。通过MTT法测定头孢氨苄、醋酸盐和配合物对乳腺癌细胞(MCF-7)和人肝癌细胞(HepG-2)的体外抗肿瘤活性,结果表明配合物1和2对MCF-7和HepG-2癌细胞均具有一定的抑制增殖活性。     

二齿肼基硫代甲酸苄酯席夫碱锌配合物的合成、晶体结构和抗肿瘤活性

以2,4-二氯苯甲醛缩肼基二硫代甲酸对氯苄酯为配体与锌盐反应合成了配合物Zn(L)2,L=2,4-二氯苯甲醛缩肼基二硫代甲酸对氯苄酯阴离子。通过元素分析和红外光谱对配合物进行了表征,并用X-射线单晶衍射测定了配合物的单晶结构。配合物属于单斜晶系,P21/n空间群,a=1.242 6(10)nm,b=1.024 4(11)nm,c=2.840 2(2)nm,β=101.740 0(10)°,Mr=842.81,V=3.539 7(5)nm3,Z=4,μ=1.412 mm-1,Dc=1.582 g.cm-3,F(000)=1 696,R1=0.039 0,wR2=0.086 2(观察衍射点)和R1=0.164 0,wR2=0.099 6(全部衍射点),Final GooF=1.015。在配合物的晶体结构中,中心锌离子与2个二齿席夫碱配体中的2个硫原子和2个氮原子形成四配位四面体构型。抗肿瘤活性实验采用了MTT比色法,初步研究表明配合物对人胃癌细胞增殖具有明显的抑制作用。     

吡唑铜(Ⅱ)配合物的合成、晶体结构及性质

本文报道了Cu(Ⅱ)的吡唑和硫氰酸根混合配体配合物[Cu(pz)₄(NCS)₂](1)(pz=吡唑)的合成、晶体结构及性质.配合物属单斜晶系,C2/c空间群,a=1.1520(4) nm,b=1.2247(4) nm,c=1.4188(5), β=106.747(8)°, Z=4, R₁=0.0554, wR₂=0.1420.配合物中Cu(Ⅱ)与4个吡唑环上的4个N原子及2个NCS^-的N原子配位形成4+2型拉长八面体配位环境,4个吡唑环上的N原子占据赤道位置, 2个NCS^-的N原子占据轴向位置.对配合物的IR、UV-Vis、ESR进行表征和分析.比较不同轴向配体对结构和性质的影响.     

三嗪-吡唑钌配合物的合成、结构及光催化活性

光催化具有无污染、安全高效等优点,已成为环保领域的研究热点。 本文选择2,4-二(3,5-二甲基吡唑)-6-二乙基胺-1,3,5-三嗪(L₁)和2, 6-二[3-(5-甲基吡唑基)]吡啶(L₂)为配体、以RuCl₃为金属源,合成了3种配合物[Ru(L₁)Cl₃](1)、[Ru(L₂)₂]·Cl₃(2)和[Ru(L₂)₂]·(H₂BTC)·(HBTC)·H₂O(3),同时进行了IR、UV-Vis、TG及X射线衍射等表征,并对配合物在光催化降解罗丹明B方面进行了探讨,结果表明,配合物13均具有一定程度的光降解效果,降解效果分别为46.8%、44.7%和40.4%。 相同条件下,加入H₂O₂后的配合物13的降解效果比金属盐、配体及H₂O₂单独存在时的降解效果好。     

新型吡唑Schiff碱及金属配合物的合成和抑菌活性

以3-氨基-4-氰基吡唑和芳醛为原料合成了10个新型吡唑Schiff碱及铜(II)、镍(II)、锌(II)、钴(II) 4个金属配合物. 用元素分析, IR, 1H NMR及单晶解析表征了Schiff碱及金属配合物的结构. 测定了Schiff碱及金属配合物对金黄色葡萄球菌、大肠杆菌、枯草杆菌和绿脓杆菌的抑菌活性. 生物活性研究表明, Schiff碱及金属配合物对金黄色葡萄球菌、大肠杆菌和绿脓杆菌都有较好的抑菌效果, 其中铜(II)和锌(II)配合物对金黄色葡萄球菌和大肠杆菌的抑菌活性最好.     

钴配合物的合成晶体结构及活性研究

The complex [Co₂Cl₂(EGTB)]·(ClO₄)₂·5H₂O was synthesized in methanol-aqueous solution and its crystal structure was determined by X-ray diffraction method. The crystal belongs to monoclinic with space group of P2₁/c. The cell parameters are a=1.42231(2)nm,b=2.53181(3)nm,c=1.43392(2)nm,β=102.0518(5)°, Z=4, F(000)=2360,D_c=1.508g·cm^-3, The final R=0.0788,wR₂=0.232, The catalytic rate constant of the dismutation of superoxide radicals has been obtained by means of photo reduction of nitroblue tetrazolium(NBT),and it is 1.875×10⁶mol^-1·L·s^-1.     

含苯并咪唑锌配合物的合成、表征及晶体结构

The complex of [N,N,N′,N′-tetrakis(2-benzimida zolyl methyl)-1,4-diethylene amino]-glycol ether (EGTB) with zinc(Ⅱ), [Zn₂(EGTB)Cl₂](ClO₄)2·CH₃OH·3H₂O was synthesized and characterized with element analysis , UV and IR spectroscopy, and X-ray diffraction method. The crystal belongs to monoclinic with space group of P2₁/c. The cell parameters are a=1.437 6(2) nm, b=2.526 50(4) nm, c=1.435 31(2) nm, β=101.7037(8) °, Z=4, F(000)=2 376, D_c=1.503g·cm^-3, The final R=0.080 4, wR₂=0.2236. Biological activities of the complexe was traced by UV-Vis spectrum. The result demonstrates that the complexe has good catalytic abliliy. CCDC: 180994.     

芳酰腙铜(Ⅱ)和锌(Ⅱ)配合物的合成、晶体结构及抗菌活性

合成了一对结构类似的双核铜和锌配合物,Cu₂(L¹)₂(1)和[Zn₂(L²)₂(CH₃OH)₂] (2),其中L¹和L²分别是2-溴-N''-(2-羟基-5-甲基苯亚甲基)苯甲酰肼(H₂L¹)和2-氯-N''-(2-羟基-5-甲基苯亚甲基)苯甲酰肼(H₂L²)的二价阴离子,通过元素分析、红外光谱以及单晶X射线衍射表征了它们的结构。配合物1以三斜晶系P1空间群结晶,其晶体学参数:a=0.91411(6) nm,b=1.18004(7) nm,c=1.35936(9) nm,α=101.928(2)°,β=91.399(2)°,γ=107.873(2)°,V=1.3593(2) nm³,Z=2,R₁=0.0540,wR₂=0.1189,GOF=0.970。配合物2以单斜晶系P2₁/c空间群结晶,其晶体学参数:a=1.21697(9) nm,b=1.21496(9) nm,c=1.21283(9) nm,β=110.939(1)°,V=1.6748(2) nm³,Z=2,R₁=0.0341,wR₂=0.0689,GOF=1.024。X射线分析表明2个化合物都是中心对称的双核配合物,其中配合物1中的Cu原子是平面正方形配位构型,配合物2中的Zn原子是四方锥配位构型。还通过MTT法研究了这两个配合物的抗细菌(大肠杆菌,金黄色葡萄球菌,枯草芽孢杆菌和铜绿色假单胞菌)和抗真菌(白假丝酵母菌和黑曲霉菌)活性。     

阿司匹林铜(Ⅱ)配合物的合成、晶体结构和抗肿瘤活性

合成了阿司匹林铜(Ⅱ)配合物,通过红外、X射线单晶衍射对其结构进行了表征。配合物属单斜晶系,P21/n空间群,晶胞参数为a=8.211(5)nm,b=10.419(5)nm,c=21.003(5)nm,β=98.021(5)°,V=1779.2(14)nm3,Z=4。采用紫外光谱和荧光光谱法及循环伏安法研究了配合物与小牛胸腺DNA(ct-DNA)的相互作用。采用MTT法测定了配合物对体外培养人乳腺癌MCF-7和胃癌MGC-803细胞的抑制活性。当配合物浓度为120μmol/L时,对2种细胞增殖的抑制率分别为80.01%和70.16%。     

含氟喹诺酮双核铜(Ⅱ)配合物的合成、晶体结构和生物活性

A new binuclear copper(Ⅱ) complex containing fluoroquinolone ligand， [Cu₂(cfc)₂(bpy)₂(pip)]·6H₂O， was synthesized and its crystal structure was solved. The formula of the complex is C₂₅H₂₆ClCuFN₄O₆， and the crystal-lography data are as follows， triclinic， space group P1， a=6.874(2)?， b=10.761(3)?， c=17.976(5)?， α=80.071(6)°， β=85.253(6)°， γ=79.109(6)°， V=1284.5(6)?3， D=1.542g·cm^-3， F(000)=614， and Z=2. R₁=0.0776 and wR₂=0.2235(I >2σ(I)). The copper atom is five-coordinate with square-based pyramidal geometry and involves two nitrogen atoms from bpy， two oxygen atoms from cfc and one nitrogen atom from pip anion. The stacking effect between cfc and bpy ligands from two neighboring molecules was observed. Both ligand and complex were assayed against gram-positive and gram-negative bacteria by doubling dilutions method， the complex shows the same minimal inhibitory concentration (MIC) as the corresponding ligand against S.Aureus and E.Coli bacteria. The inhibitory effect of the ligand and complex on leukemia HL-60 cell line and liver cancer BEL-7402 cell line have been measured by using MTT (Methyl-Thiazol- Tetrozolium) and SRB (Sulphurhodamin B) assay methods. The results indicated that the complex has strong inhibitory effect on HL-60 cell line and on BEL-7402 cell line. CCDC： 191087.     

双核铜(Ⅱ)-氟喹诺酮-邻菲咯啉混配配合物的合成、晶体结构和抗肿瘤活性

A new binuclear copper (Ⅱ) complex with 1,10-phen and fluoroquinolone ligands, [Cu₂(cfc)₂(phen)₂(pip)](NO₃)₂(CO)₂,was synthesized and its crystal structure was solved.The formula of the complex is C₂₈H₂₄ClCuFN₅O₇, and the crystallography data are as follows, triclinic, space group P1, a=0.80372(6)nm, b=0.94712 (7)nm, c=1.67826(13)nm, α=88.5650(10)°, β=80.9920(10)°, γ=70.2780(10)°, V=1.18722(6)nm³, Z=2, D=1.848g· cm^-3, F(000)=676. R₁=0.0627 and wR₂=0.1684 (I>2σ(I)). The copper atom is five- coordinate with square-based pyramidal geometry and involves two nitrogen atoms from phen, two oxygen atoms from cfc and one nitrogen atom from pip anion. The stacking effect between cfc and phen ligands from two neighboring molecules was observed. FT-IR spectrum of the complex was also discussed. Both ligand and complex were assayed against gram-positive and gram-negative bacteria by doubling dilutions method； the complex shows the same mini-mal inhibitory concentration (MIC) as the corresponding ligand against S. Aureus, E. Coli and M. Lutens bac-teria. The inhibitory effect of the ligand and complex on leukemia HL-60 cell line and liver cancer BEL-7402 cell line have been measured by using MTT (Methyl-Thiazol- Tetrozolium) and SRB (Sulphurhodamin B) assay meth-ods, respectively. The results indicated that the complex has strong inhibitory effect on HL-60 and BEL-7402 cell line. CCDC: 203964.     

Synthesis, Crystal Structure and Antimicrobial Activity of a Novel Ni(II) Complex

A new nickel(II) complex, C34H38N8NiO4, has been prepared and charac- terized by X-ray diffraction analysis. It crystallizes in the monoclinic system, space group P21/c with a = 11.715(5), b = 12.328(5), c =11.113(5) , β = 92.589(5)°, Z = 2, Dc = 1.411 g/cm3, μ = 0.658 mm-1, the final R = 0.0427 and wR = 0.1099 for 2229 observed reflections with I > 2σ(I). The complex is a centrosymmetric plane in which nickel(II) is coordinated in a regular octahedron to the ligand phenytoin through the nitrogen atoms of ethylenediamine, imine and amine. The complex was valued for its antimicrobial activity against bacterial strands using the agar diffusion method, and found to be active against the four test bacterial organisms. Preliminary screening for antimicrobial activities showed that the title complex is quite active against standard strains of Salmonella species, Staphylococcus aureus, Bacillus pumilus and Eschierichia coli.     

Template Synthesis and Structure of Dinuclear Zinc Complex with Three Kinds of Pyrazole Ligands

ＴｅｍｐｌａｔｅＳｙｎｔｈｅｓｉｓａｎｄＳｔｒｕｃｔｕｒｅｏｆＤｉｎｕｃｌｅａｒＺｉｎｃＣｏｍｐｌｅｘｗｉｔｈＴｈｒｅｅＫｉｎｄｓｏｆＰｙｒａｚｏｌｅＬｉｇａｎｄｓＺＨＡＮＧＷｅｎ－Ｘｉｎｇ；ＭＡＣｈａｎｇ－Ｑｉｎ；ＷＡＮＧＸｕ－Ｎｉｎｇ；ＹＵＺｈｅ...     

Synthesis,Crystal Structure and Catechol Oxidase Mimic Activity of a Dinuclear Copper Complex

A dinuclear copper complex [Cu2LCl2](ClO4)2(L = 2,2'-(piperazine-1,4-diyl)bis-(N,N-bis(pyridine-2-ylmethyl)ethan-1-amine)) has been synthesized and structurally characterized. It crystallizes in triclinic, space group P1 with a = 8.5707(9), b = 10.5083(12), c = 11.4878(13), α = 76.197(2), β = 88.271(2), γ = 87.855(2)o, V = 1003.81(19)3, Z = 1, F(000) = 478, Dc = 1.544 Mg/m3, Mr = 933.60, μ = 1.383 mm-1, the final R = 0.0669 and wR = 0.1486 for 3675 observed reflections with I 2ρ(I). Its catechol oxidase mimic activity was studied spectroscopically by using 3,5-di-tert-butylcatechol(3,5-DTBC) as the substrate. The results showed that the kinetics of catechol catalyzed by the complex accorded with the Michaelis-Mentent equation, and the catechol oxidase catalytic activity of the complex increased with increasing the pH values.     

一种有机锡化合物的合成、晶体结构、抗肿瘤及荧光性能

通过异烟肼和4-N,N-二羟乙基苯甲醛来合成一种席夫碱及其锡配合物,并通过核磁、元素分析以及X-射线单晶衍射来进行结构表征。该平面构型的席夫碱采取二齿配位模式,其中的-C=N-在配位后由反式变为顺式。晶体结构数据以及荧光光谱中的显著红移现象表明锡配合物中的π-共轭体系通过配位反应得以延展。体外细胞毒性数据表明,席夫碱配体及其锡配合物对于A-549,MCF-7和Hela等肿瘤细胞的生长抑制活性要强于顺铂。还通过紫外可见光谱及荧光光谱初步研究了两种化合物与DNA的相互作用,结果表明锡配合物可能通过共价结合来导致DNA双螺旋链变形,而席夫碱分子中的氢键效应及其长平面结构可能会阻碍其嵌入DNA双螺旋链。     

一种有机锡化合物的合成、晶体结构、抗肿瘤及荧光性能(英文)

通过异烟肼和4-N,N-二羟乙基苯甲醛来合成一种席夫碱及其锡配合物,并通过核磁、元素分析以及X-射线单晶衍射来进行结构表征。该平面构型的席夫碱采取二齿配位模式,其中的-C=N-在配位后由反式变为顺式。晶体结构数据以及荧光光谱中的显著红移现象表明锡配合物中的π-共轭体系通过配位反应得以延展。体外细胞毒性数据表明,席夫碱配体及其锡配合物对于A-549,MCF-7和Hela等肿瘤细胞的生长抑制活性要强于顺铂。还通过紫外可见光谱及荧光光谱初步研究了两种化合物与DNA的相互作用,结果表明锡配合物可能通过共价结合来导致DNA双螺旋链变形,而席夫碱分子中的氢键效应及其长平面结构可能会阻碍其嵌入DNA双螺旋链。     

Synthesis, Crystal Structure and Biological Activity of a Planar Copper Complex Derived from S-benzyldithiocarbazate

A planar transition metal complex Cu(L)2 (L = (E)-benzyl-2-(4-nitrobenzylidene)-hydrazinecarbodithioate) has been prepared and determined by X-ray single-crystal diffraction. The crystal belongs to the monoclinic system,space group P21/c with a = 6.7101(11),b = 16.952(3),c = 13.962(3) ,β = 92.458(4)°,V = 1586.7(5) 3,Z = 4,Mr = 724.33,Dc = 1.516 g·m-3,μ = 0.998 mm-1,F(000) = 742,S = 1.021,R = 0.0634 and wR = 0.1077 for 813 observed reflections with Ⅰ 2σ(Ⅰ) and 205 parameters. In the molecular structure of the title complex,the copper atom exhibits a slightly distorted square-planar geometry in which the basal plane is defined by two N and two S atoms from two bidentate ligands. The complex was evaluated for its antitumor activity against two kinds of cell lines (MKN45 and HepG2) by MTT method. The preliminary bioassay indicates that the complex exhibits weak antitumor activity.     

二正丁基锡(Ⅳ)双(二茂铁硫代甲酸酯)配合物的合成、结构表征及其体外抗癌活性研究

以二茂铁硫代甲酸和二正丁基氧化锡反应,合成了未见报道的二正丁基锡新型配合物(n—Bu)2Sn(FeCOS)2[Fe=(η^5-C5H5)Fe(η^5-C5H4)]．通过元素分析、红外光谱和核磁共振(^1H,^13C,^119Sn)谱等分析手段对配合物的组成和结构进行了表征．用X射线单晶衍射分析法测定了该配合物的晶体结构．晶体属四方晶系,空间群P421m,晶胞参数α=2．3351(7)nm,6=2．3351(7)nm,c=0．5870(2)nm,V=3．2005(18)nm^3,Z=4,De=1．501Mg／m^3,μ（Mo Kα)=1．823mm^-1,F(000)=1464．最终可靠因子R1=0．0733,wR2=0．1173．配合物中锡原子与2个S原子、2个O原子和2个C原子形成扭曲的八面体几何构型．体外抗癌活性测试结果表明,该配合物对人体的白血病HL-60、结肠癌HCT-8、胃癌BGC-823和鼻咽癌KB等癌细胞均有很好的抑制能力．